October 08, 2015
Telemedicine helps UAB take pulmonary rehabilitation into the home via smartphone technology, in an effort to reduce hospital readmissions from COPD.
Macrophage cells require agility to scavenge and digest dead cells and prevent an immune response to self. In lupus, the macrophages lose that agility.
A UAB researchers suggests that autoimmune disease therapy may be an effective treatment for idiopathic pulmonary fibrosis
An experimental lung-volume-reduction procedure using one-way valves shows promise for a UAB patient.
June 01, 2015
UAB’s William Bailey honored by his alma mater with a lifetime achievement award for 50 years of exemplary service in medicine.
UAB was part of a promising international study of a combination therapy for patients with the most common cystic fibrosis mutation.
April 07, 2015
UAB is implanting one-way valves in patients with severe emphysema in an effort to reduce their overall lung volume, which improves lung function.
April 02, 2015
January 28, 2015
January 26, 2015
A UAB researcher is looking for clues in the cell walls of fungi to alleviate severe fungal reactions in patients with asthma.
March 11, 2014
ECMO, or extra corporeal membrane oxygenation, takes on the function of the heart and lungs by routing the patient’s blood into the machine where carbon dioxide is removed and oxygen is added.
May 21, 2014
UAB researchers participated in a multi-site study that disproved a once-promising theory that statins might have a beneficial effect on lung function.
May 05, 2014
April 09, 2014
In findings published April 9 in Science Translational Medicine, the UAB team describes the mechanism that contributes to persistent fibrosis in the aged, and suggests targets that may help reverse the buildup of scar tissue.
January 16, 2014
UAB offers U.S. Preventive Services Task Force-recommended CT scans for lung cancer, the leading cause of cancer deaths in the United States, causing more deaths than breast, colon and prostate cancer combined.
UAB investigators have found a new pathway that contributes to an often fatal lung disease with no cure and no effective treatments, and possibly a way to shut that pathway down.